Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
Interest Income Expense
Sonoma Pharmaceuticals Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Interest Income Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Interest Income Expense
$178m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Interest Income Expense
-$877m
|
CAGR 3-Years
-131%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
Interest Income Expense
$2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Interest Income Expense
-$811m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-1%
|
|
Eli Lilly and Co
NYSE:LLY
|
Interest Income Expense
-$332.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-23%
|